DCF — PELHAM MEDICAL CENTER
Enterprise Value: $87.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$87.5M
Enterprise Value
$22.3M
PV of Cash Flows
$65.2M
PV of Terminal Value
$105.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $141.3M | $12.0M | 8.0% | $3.9M | $3.6M |
| Year 2 | $145.6M | $13.8M | 9.0% | $5.1M | $4.2M |
| Year 3 | $149.9M | $15.7M | 10.0% | $6.4M | $4.8M |
| Year 4 | $154.4M | $17.0M | 11.0% | $7.2M | $4.9M |
| Year 5 | $159.1M | $17.9M | 11.0% | $7.7M | $4.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $87.5M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$137.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999795946203
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5